MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-30-2026
Actinium Pharmaceuticals Historical Prices 2011-2026 | ATNM
Annual Historical Prices Actinium Pharmaceuticals
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.99 | 1.61 | 7.83 | 9.34 | 5.4 | 8.06 | 7.14 | 17.6 | 12.9 | 42.3 | 60.3 | 93.6 | 162 | 45 | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 162 | 0.99 | 33.9 |
Historical Prices of other stocks in the Biotechnology industry
| Issuer | Historical Prices | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Applied Genetic Technologies Corporation
AGTC
|
0.3 | - | - | $ 26.5 M |  USA |
 |
MorphoSys AG
MOR
|
18.2 | - | 2.43 % | $ 254 M |  Germany |
 |
Allakos
ALLK
|
1.31 | - | - | $ 28.6 M | USA |
 |
Advaxis
ADXS
|
0.31 | - | -9.65 % | $ 45.9 M | USA |
 |
Alterity Therapeutics Limited
ATHE
|
0.58 | $ 4.57 | -0.22 % | $ 11 B |  Australia |
 |
Akouos
AKUS
|
5.34 | - | 0.23 % | $ 488 M | USA |
 |
AlloVir
ALVR
|
9.78 | - | 4.14 % | $ 49.1 M | USA |
 |
Compugen Ltd.
CGEN
|
2.1 | $ 2.65 | -2.93 % | $ 248 M |  Israel |
 |
I-Mab
IMAB
|
0.68 | - | - | $ 866 M |  China |
 |
Aeglea BioTherapeutics
AGLE
|
12 | - | - | $ 1.01 B | USA |
 |
Ampio Pharmaceuticals
AMPE
|
0.82 | - | -11.43 % | $ 502 K | USA |
 |
Midatech Pharma plc
MTP
|
0.29 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Aptorum Group Limited
APM
|
0.91 | $ 0.88 | - | $ 6.47 M | China |
 |
Biophytis SA
BPTS
|
0.33 | - | -13.47 % | $ 169 M |  France |
 |
Genfit SA
GNFT
|
3.36 | - | 2.54 % | $ 160 B | France |
 |
ACADIA Pharmaceuticals
ACAD
|
19.3 | $ 22.5 | -0.75 % | $ 3.73 B | USA |
 |
Applied Molecular Transport
AMTI
|
0.57 | - | - | $ 10.1 M | USA |
 |
AIkido Pharma
AIKI
|
3.17 | - | 1.93 % | $ 17.4 M | USA |
 |
Applied Therapeutics
APLT
|
6.42 | - | - | $ 8.42 M | USA |
 |
Aptinyx
APTX
|
0.14 | - | -39.0 % | $ 4.57 M | USA |
 |
Galapagos NV
GLPG
|
28.9 | $ 27.55 | -3.08 % | $ 2.69 B |  Belgium |
 |
Genmab A/S
GMAB
|
33.5 | $ 25.89 | -3.36 % | $ 16 B |  Danmark |
 |
Avenue Therapeutics
ATXI
|
0.42 | - | -52.27 % | $ 4.45 M | USA |
 |
Aeterna Zentaris
AEZS
|
5.72 | - | 5.93 % | $ 314 M |  Canada |
 |
Ayala Pharmaceuticals
AYLA
|
0.5 | - | - | $ 7.46 M | Israel |
 |
AgeX Therapeutics
AGE
|
13 | - | -10.17 % | $ 12.2 K | USA |
 |
Aravive
ARAV
|
1.66 | - | -13.39 % | $ 1.45 M | USA |
 |
Aridis Pharmaceuticals
ARDS
|
0.22 | - | 17.91 % | $ 11.1 M | USA |
 |
Atreca
BCEL
|
1.27 | - | -11.76 % | $ 5.79 M | USA |
 |
BioNTech SE
BNTX
|
91.2 | $ 100.4 | -1.63 % | $ 27.2 B | Germany |
 |
Brainstorm Cell Therapeutics
BCLI
|
1.26 | - | -2.5 % | $ 5.88 M | USA |
 |
BioDelivery Sciences International
BDSI
|
3.1 | - | -4.8 % | $ 255 M | USA |
 |
Innoviva
INVA
|
24.1 | $ 23.23 | -1.94 % | $ 1.57 B | USA |
 |
Innate Pharma S.A.
IPHA
|
1.41 | $ 1.45 | 3.57 % | $ 235 M | France |
 |
Aquestive Therapeutics
AQST
|
4.37 | $ 4.07 | -0.61 % | $ 435 M | USA |
 |
Inventiva S.A.
IVA
|
3.07 | $ 4.96 | -1.1 % | $ 138 M | France |
 |
Jaguar Health
JAGX
|
0.41 | $ 0.23 | -5.27 % | $ 536 K | USA |
 |
Arcutis Biotherapeutics
ARQT
|
27.1 | $ 22.56 | -3.13 % | $ 2.87 B | USA |
 |
KalVista Pharmaceuticals
KALV
|
15.5 | $ 26.71 | 38.8 % | $ 1.44 B | Britain |
 |
Autolus Therapeutics plc
AUTL
|
1.21 | $ 1.4 | -5.74 % | $ 373 M | Britain |
 |
Kamada Ltd.
KMDA
|
8.5 | $ 8.15 | - | $ 260 M | Israel |
 |
Aptose Biosciences
APTO
|
3.32 | - | -45.71 % | $ 1.2 M | Canada |
 |
AstraZeneca PLC
AZN
|
74.2 | - | - | $ 96.9 B | Britain |
 |
AVROBIO
AVRO
|
1.27 | - | 1083.1 % | $ 745 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
2.92 | $ 2.88 | -1.03 % | $ 4.74 M | Israel |
 |
BeiGene, Ltd.
BGNE
|
185 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Akero Therapeutics
AKRO
|
48.4 | - | - | $ 3.67 B | USA |